NFKB1 and benign prostatic hyperplasia: In summary, our results showed that FCT treatment reduced DHT and 5-alpha reductase levels, prostate weight in the BPH-rat model, and regulated cell proliferation and apoptosis through modulating NF-kB and pro-inflammatory cytokines, including TNF-α, IL-6, IL-8, and IL-1β.